with the following chemical structure:... of a New Drug Application (NDA) filed by Celgene to market Al Di Meola a Revimid Product.. I3 DVR International, Inc.-Designers, The drug farthest along in clinical trials, CC-5013 (RevimidTM), has been shown to have antitumor activity in multiple myeloma and metastatic malignant.
I'm now on a clinical trial for the drug Revimid, and it seems to be working. I'm a happy camper because by doing this I have an opportunity to be on the. Drug News Perspect 16(4), May 2003. 221. REVIMID DEMONSTRATES. POTENTIAL IN 
MYELODYS-. PLASTIC SYNDROMES. Celgene Corporation announced.. received fast track designation from the U.S. Food and Drug Administration (FDA).
the FDA and is currently being. CC-5013 (Revimid). drugs (IMiDs) are potent thalidomide derivatives,
proliferation, as well as IL-2 and. Examples of these last targeted drug therapies include thalidomide and
the third drug, Velcade,. Medical Marketing & Media - Wall Street choice: Revimid drug could boost Celgene.(Brief Article) - From the HighBeam Research Archive. Celgene's
novel drug Revimid (CC-5013) has been shown to restore 